This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Emulate, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Sushma Jadalannagari: Innovator in Microfluidic Kidney-on-Chip Technology
Introduction
Sushma Jadalannagari is a prominent inventor based in Chelmsford, MA (US). She has made significant contributions to the field of microfluidics, particularly in the development of kidney-on-chip technologies. With a total of 2 patents, her work is paving the way for advancements in drug testing and personalized medicine.
Latest Patents
One of her latest patents is focused on the microfluidic proximal tubule kidney-on-chip. This invention relates to microfluidic devices, methods, and systems designed to replicate human kidney functions. The kidney-on-chip technology includes various components such as the Proximal Tubule-Kidney-Chip, Glomerulus (Kidney)-Chip, and Collecting Duct (Kidney)-Chip. These devices are instrumental in drug testing, including drug transport and renal clearance. They also facilitate the determination of drug-drug interactions and their effects on renal transporter functions. Importantly, these innovations are applicable in pre-clinical and clinical drug development for treating kidney diseases and advancing personalized medicine.
Career Highlights
Sushma Jadalannagari is currently employed at Emulate, Inc., where she continues to innovate in the field of microfluidics. Her work is characterized by a commitment to improving healthcare through technology.
Collaborations
Some of her notable coworkers include Kyung-Jin Jang and Hyoungshin Park, who contribute to the collaborative environment at Emulate, Inc.
Conclusion
Sushma Jadalannagari's contributions to microfluidic kidney-on-chip technology are significant and impactful. Her inventions are set to revolutionize drug testing and treatment for kidney diseases, showcasing her dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
